PURPOSE: To evaluate the safety of hyperpolarized helium 3 ((3)He) magnetic resonance (MR) imaging. MATERIALS AND METHODS: Local institutional review board approval and informed consent were obtained. Physiologic monitoring data were obtained before, during, and after hyperpolarized (3)He MR imaging in 100 consecutive subjects (57 men, 43 women; mean age, 52 years +/- 14 [standard deviation]). The subjects inhaled 1-3 L of a gas mixture containing 300-500 mL (3)He and 0-2700 mL N(2) and held their breath for up to 15 seconds during MR imaging. Heart rate and rhythm and oxygen saturation of hemoglobin as measured by pulse oximetry (Spo(2)) were monitored continuously throughout each study. The effects of (3)He MR imaging on vital signs and Spo(2) and the relationship between pulmonary function, number of doses, and clinical classification (healthy volunteers, patients with asthma, heavy smokers, patients undergoing lung volume reduction surgery for severe emphysema, and patients with lung cancer) and the lowest observed Spo(2) were assessed. Any subjective symptoms were noted. RESULTS: Except for a small postimaging decrease in mean heart rate (from 78 beats per minute +/- 13 to 73 beats per minute +/- 11, P < .001), there was no effect on vital signs. A mean transient decrease in Spo(2) of 4% +/- 3 was observed during the first minute after gas inhalation (P < .001) in 77 subjects who inhaled a dose of 1 L for 10 seconds or less, reaching a nadir of less than 90% at least once in 20 subjects and of less than 85% in four subjects. There was no correlation between the lowest Spo(2) and pulmonary function parameters other than baseline Spo(2) (r = 0.36, P = .001). The lowest mean Spo(2) varied by 1% between the first and second and second and third doses (P < .001) and was unrelated to clinical classification (P = .40). Minor subjective symptoms were noted by 10 subjects. No serious adverse events occurred. CONCLUSION: Hyperpolarized (3)He MR imaging can be safely performed in healthy subjects, heavy smokers, and those with severe obstructive airflow limitation, although unpredictable transient desaturation suggests that potential subjects should be carefully screened for comorbidities.
PURPOSE: To evaluate the safety of hyperpolarized helium 3 ((3)He) magnetic resonance (MR) imaging. MATERIALS AND METHODS: Local institutional review board approval and informed consent were obtained. Physiologic monitoring data were obtained before, during, and after hyperpolarized (3)He MR imaging in 100 consecutive subjects (57 men, 43 women; mean age, 52 years +/- 14 [standard deviation]). The subjects inhaled 1-3 L of a gas mixture containing 300-500 mL (3)He and 0-2700 mL N(2) and held their breath for up to 15 seconds during MR imaging. Heart rate and rhythm and oxygen saturation of hemoglobin as measured by pulse oximetry (Spo(2)) were monitored continuously throughout each study. The effects of (3)He MR imaging on vital signs and Spo(2) and the relationship between pulmonary function, number of doses, and clinical classification (healthy volunteers, patients with asthma, heavy smokers, patients undergoing lung volume reduction surgery for severe emphysema, and patients with lung cancer) and the lowest observed Spo(2) were assessed. Any subjective symptoms were noted. RESULTS: Except for a small postimaging decrease in mean heart rate (from 78 beats per minute +/- 13 to 73 beats per minute +/- 11, P < .001), there was no effect on vital signs. A mean transient decrease in Spo(2) of 4% +/- 3 was observed during the first minute after gas inhalation (P < .001) in 77 subjects who inhaled a dose of 1 L for 10 seconds or less, reaching a nadir of less than 90% at least once in 20 subjects and of less than 85% in four subjects. There was no correlation between the lowest Spo(2) and pulmonary function parameters other than baseline Spo(2) (r = 0.36, P = .001). The lowest mean Spo(2) varied by 1% between the first and second and second and third doses (P < .001) and was unrelated to clinical classification (P = .40). Minor subjective symptoms were noted by 10 subjects. No serious adverse events occurred. CONCLUSION: Hyperpolarized (3)He MR imaging can be safely performed in healthy subjects, heavy smokers, and those with severe obstructive airflow limitation, although unpredictable transient desaturation suggests that potential subjects should be carefully screened for comorbidities.
Authors: E E de Lange; J P Mugler; J R Brookeman; J Knight-Scott; J D Truwit; C D Teates; T M Daniel; P L Bogorad; G D Cates Journal: Radiology Date: 1999-03 Impact factor: 11.105
Authors: Edwin J R van Beek; Catherine Hill; Neil Woodhouse; Stanislao Fichele; Sally Fleming; Bridget Howe; Sandra Bott; Jim M Wild; Christopher J Taylor Journal: Eur Radiol Date: 2006-08-29 Impact factor: 5.315
Authors: Colm J McMahon; Jonathan D Dodd; Catherine Hill; Neil Woodhouse; Jim M Wild; Stan Fichele; Charles G Gallagher; Stephen J Skehan; Edwin J R van Beek; James B Masterson Journal: Eur Radiol Date: 2006-07-27 Impact factor: 5.315
Authors: Kimiknu Mentore; Deborah K Froh; Eduard E de Lange; James R Brookeman; Alix O Paget-Brown; Talissa A Altes Journal: Acad Radiol Date: 2005-11 Impact factor: 3.173
Authors: Jason C Woods; Cliff K Choong; Dmitriy A Yablonskiy; John Bentley; Jonathan Wong; John A Pierce; Joel D Cooper; Peter T Macklem; Mark S Conradi; James C Hogg Journal: Magn Reson Med Date: 2006-12 Impact factor: 4.668
Authors: Panos Koumellis; Edwin J R van Beek; Neil Woodhouse; Stan Fichele; Andrew J Swift; Martyn N J Paley; Catherine Hill; Chris J Taylor; Jim M Wild Journal: J Magn Reson Imaging Date: 2005-09 Impact factor: 4.813
Authors: Mario Castro; Sean B Fain; Eric A Hoffman; David S Gierada; Serpil C Erzurum; Sally Wenzel Journal: J Allergy Clin Immunol Date: 2011-06-02 Impact factor: 10.793
Authors: Nanae Tsuchiya; Mark L Schiebler; Michael D Evans; Robert V Cadman; Ronald L Sorkness; Robert F Lemanske; Daniel J Jackson; Nizar N Jarjour; Loren C Denlinger; Sean B Fain Journal: Pediatr Radiol Date: 2020-01-24
Authors: A J Hajari; D A Yablonskiy; J D Quirk; A L Sukstanskii; R A Pierce; G Deslée; M S Conradi; J C Woods Journal: J Appl Physiol (1985) Date: 2011-02-24
Authors: James D Quirk; Barbara A Lutey; David S Gierada; Jason C Woods; Robert M Senior; Stephen S Lefrak; Alexander L Sukstanskii; Mark S Conradi; Dmitriy A Yablonskiy Journal: Radiology Date: 2011-07-06 Impact factor: 11.105
Authors: Laura L Walkup; Robert P Thomen; Teckla G Akinyi; Erin Watters; Kai Ruppert; John P Clancy; Jason C Woods; Zackary I Cleveland Journal: Pediatr Radiol Date: 2016-08-05
Authors: Bastiaan Driehuys; Santiago Martinez-Jimenez; Zackary I Cleveland; Gregory M Metz; Denise M Beaver; John C Nouls; S Sivaram Kaushik; Rafael Firszt; Christine Willis; Kevin T Kelly; Jan Wolber; Monica Kraft; H Page McAdams Journal: Radiology Date: 2011-11-04 Impact factor: 11.105
Authors: Rohan S Virgincar; Zackary I Cleveland; S Sivaram Kaushik; Matthew S Freeman; John Nouls; Gary P Cofer; Santiago Martinez-Jimenez; Mu He; Monica Kraft; Jan Wolber; H Page McAdams; Bastiaan Driehuys Journal: NMR Biomed Date: 2012-10-13 Impact factor: 4.044
Authors: David S Gierada; Jason C Woods; Andrew J Bierhals; Seth T Bartel; Jon H Ritter; Cliff K Choong; Nitin A Das; Cheng Hong; Thomas K Pilgram; Yulin V Chang; Richard E Jacob; James C Hogg; Richard J Battafarano; Joel D Cooper; Bryan F Meyers; G Alexander Patterson; Dmitriy A Yablonskiy; Mark S Conradi Journal: J Magn Reson Imaging Date: 2009-10 Impact factor: 4.813